Journal of Applied Physiology AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 105: 749-751, 2008. First published March 20, 2008; doi:10.1152/japplphysiol.90336.2008
8750-7587/08 $8.00
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
105/2/749    most recent
90336.2008v2
90336.2008v1
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aliverti, A.
Right arrow Articles by Macklem, P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aliverti, A.
Right arrow Articles by Macklem, P. T.

POINT-COUNTERPOINT

The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles

Andrea Aliverti1 and Peter T. Macklem2

1TBL-Lab
Dipartimento di Bioingegneria
Politecnico di Milano, Italy
e-mail: andrea.aliverti{at}polimi.it2Meakins-Christie Laboratories
McGill University Health Centre
Research Institute
Montreal, Canada

No doubt dynamic hyperinflation and lack of oxidative capacity of skeletal muscles are important causes of exercise limitation in COPD. O'Donnell and Webb and Debigaré and Maltais will convince the reader of this by the elegant experiments they have performed. The thesis we will put forward is that during the natural history of COPD the primary factors leading to impairment of exercise performance are an increase in energy demands combined with a decrease in supplies and that both of these result from excessive recruitment of expiratory muscles. We argue that both dynamic hyperinflation and reduced oxidative capacity are secondary adaptations resulting from this primary abnormality.

Increased energy demands during exercise in COPD.   Energy demands are increased in COPD because of the high O2 cost of breathing (VO2resp). In health, VO2resp is only 1–3 ml O2/l breathed, whereas in COPD it has been reported variously to average 6.3, 9.7, and 16.4 ml/l breathed with individual values ranging from 3.0 to 19.5 ml/l (8, 17).

The large between patient range in VO2resp probably reflects variation in the work of breathing (Wresp). During exercise, a large variation in Wresp certainly exists. In two studies, COPD patients formed two distinct groups: those that strongly recruited abdominal muscles and those that did not (5, 10). In the first (5), at an exercise workload of 10 W the work performed on the lung averaged 754 cmH2O·l–1·min–1 in recruiters but only 277 cmH2O·l–1·min–1 in nonrecruiters, although ventilation was similar. Expiratory muscle activation is the normal response to exercise (1) so the recruiters behaved normally. The problem is that in COPD, it fails to increase ventilation, because expiratory flow becomes limited by high pleural pressures. While abdominal muscle recruitment is beneficial during exercise in health (1), it is definitely harmful in COPD (4, 5).

Because Wresp was 2.7-fold greater in recruiters, we can assume that their VO2resp was twice as high as the nonrecruiters. Let's also assume that it was 12 ml O2/l in the former and 6 ml/l in the latter. The maximal exercise workload (Wmax) was 20 and 35 W in recruiters and nonrecruiters (P < 0.05), while VE at Wmax was 35.9 and 37.9 l/min, respectively (5). Thus the estimated VO2resp was 430.8 ml/min in recruiters but only 227.4 ml/min in nonrecruiters. From the measured values of VO2 at rest and during 10 W exercise and assuming that VO2 increased linearly (dVO2/dwatt is constant) the VO2 at maximal exercise workload (VO2max) was 830.0 and 1,327.5 ml O2/min, respectively, in recruiters and nonrecruiters. Subtracting VO2resp from VO2max reveals that if the respiratory muscles received all their demands there was only 399.2 ml O2 available to locomotor muscles and other body tissues in recruiters but 1,100.1 ml in nonrecruiters. The respiratory muscles demanded 53% of VO2max in recruiters but only 17%, a value close to normal (6), in nonrecruiters.

The nonrecruiters' breathing pattern was abnormal because abdominal muscles were not recruited during exercise. As a result, their exercise performance was better. However, their resting lung function was worse. Both the FEV1 and FEV1/FVC were significantly lower in nonrecruiters. This strongly suggests that as COPD progresses, patients eventually realize that abdominal muscles recruitment is bad and somehow they learn to derecruit them. Alas, without abdominal muscle contraction they dynamically hyperinflate. They can exercise a bit more, but not much (15). Thus we believe that dynamic hyperinflation results from a learned response to an inadequate supply of energy to meet demands.

Decreased energy supplies during exercise with expiratory flow limitation.   When normal subjects breathe with a Starling resistor in the expiratory line, which limits expiratory flow to ~1 l/s, exercise is limited by severe dyspnea; abdominal pressure (Pab) increases abnormally; duty cycle decreases; CO2 retention occurs, increasing Pab even more (3, 13, 14); the high expiratory pressures and short duty cycle act like a Valsalva maneuver and decrease cardiac output (Q'c) (2); as a result, O2 debt is increased by 52% (22). Expiratory flow limitation (EFL) decreases the shortening velocity of abdominal muscles, and, in accordance with their force velocity characteristics Pab increases (3). Expiratory muscle recruitment can account for 66% of the variation in Borg scale ratings of difficulty in breathing (14). None of these abnormalities can be attributed to either dynamic hyperinflation or impaired oxidative capacity of skeletal muscles.

Does this scenario occur in COPD? There is strong evidence that it does. First, there is uniform agreement that lactic acid production occurs at a very low exercise level in COPD. This suggests an imbalance between energy supply and demand, resulting in competition between respiratory and locomotor muscles for limited energy supplies (9, 12, 20). Administration of O2 improves exercise performance probably by decreasing VO2resp (7), thereby releasing more energy for locomotor muscles. This improvement should not occur if skeletal muscles were unable to use the energy available to them. Richardson et al. (19) showed that in small muscle mass exercise in COPD there was a 2.2-fold greater mass-specific power output than during whole body exercise. Locomotor muscles have a greater maximal power output in the absence of respiratory-locomotor muscle competition, Oelberg et al. (18) reported a Q'c of only 39% of predicted during exercise in COPD and when heliox was breathed, decreasing VO2resp and increasing the energy available to locomotor muscles, VO2 increased by 15% without any change in Q'c (18). If the respiratory muscles in recruiters demand 53% of VO2max, they probably demand the same share of Q'c (6), and if Q'c is only 39% predicted, locomotor muscles must be pretty ischemic. Finally Francois (21) himself reported a plateau in lower limb perfusion while exercise workload increased in COPD.

If inadequate energy to meet demands limits exercise in COPD, why is the oxidative capacity of skeletal muscles reduced? The obvious answer is that disuse and lack of energy supplies (tissue hypoxia) cause the enzymatic changes and mitochondrial abnormalities responsible for decreasing oxidative capacity. Again there is strong evidence that this is so [see Gosker et al. (11) for an outstanding review]. The myopathic changes in congestive heart failure and COPD are almost identical. They do not occur in the diaphragm because there is no disuse of this muscle. There is no reason to believe that myopathy is a primary abnormality in COPD and congestive heart failure and every reason to believe that it is secondary to disuse and tissue hypoxia. Francois refers to this when he states "...a comparable disorder has been described in chronic heart failure. Chronic reduction in oxygen availability at the cellular level...could contribute to...skeletal muscle dysfunction" (16). Francois also recognized the potential importance of respiratory-locomotor muscle competition when he wrote that in COPD "...the respiratory muscles, with [high] VO2 during exercise...might...compete with lower limb muscles for the available blood flow and O2" (21). Yes, reduced oxidative capacity, like dynamic hyperinflation, can limit exercise performance in COPD, but it is secondary to a longstanding imbalance between energy supply and demand.

We believe the long natural history of COPD results in the sequence of events during exercise shown in Fig. 1. The primary event, EFL during exercise, probably occurs when the disease is still mild and exercise is not seriously impaired. This in turn leads to an increase in force generation of expiratory muscles increasing expiratory pressures from which all the pathophysiology described above derives.


Figure 1
View larger version (25K):
[in this window]
[in a new window]

 
Fig. 1. Natural history of COPD and its results in the sequence of events during exercise.

 

REFERENCES

  1. Aliverti A, Cala SJ, Duranti R, Ferrigno G, Kenyon CM, Pedotti A, Scano G, Sliwinski P, Macklem PT, Yan S. Human respiratory muscle actions and control during exercise. J Appl Physiol 83: 1256–1269, 1997.[Abstract/Free Full Text]
  2. Aliverti A, Dellaca RL, Lotti P, Bertini S, Duranti R, Scano G, Heyman J, Lo MA, Pedotti A, Macklem PT. Influence of expiratory flow-limitation during exercise on systemic oxygen delivery in humans. Eur J Appl Physiol 95: 229–242, 2005.[CrossRef][Web of Science][Medline]
  3. Aliverti A, Iandelli I, Duranti R, Cala SJ, Kayser B, Kelly S, Misuri G, Pedotti A, Scano G, Sliwinski P, Yan S, Macklem PT. Respiratory muscle dynamics and control during exercise with externally imposed expiratory flow limitation. J Appl Physiol 92: 1953–1963, 2002.[Abstract/Free Full Text]
  4. Aliverti A, Rodger K, Dellaca RL, Stevenson N, Lo MA, Pedotti A, Calverley PM. Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD. Thorax 60: 916–924, 2005.[Abstract/Free Full Text]
  5. Aliverti A, Stevenson N, Dellaca RL, Lo MA, Pedotti A, Calverley PM. Regional chest wall volumes during exercise in chronic obstructive pulmonary disease. Thorax 59: 210–216, 2004.[Abstract/Free Full Text]
  6. Babcock MA, Pegelow DF, Harms CA, Dempsey JA. Effects of respiratory muscle unloading on exercise-induced diaphragm fatigue. J Appl Physiol 93: 201–206, 2002.[Abstract/Free Full Text]
  7. Bye PT, Esau SA, Levy RD, Shiner RJ, Macklem PT, Martin JG, Pardy RL. Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation. Am Rev Respir Dis 132: 236–240, 1985.[Web of Science][Medline]
  8. Levison H, Cherniack RM. Ventilatory cost of exercise in chronic obstructive pulmonary disease. J Appl Physiol 25: 21–27, 1968.[Free Full Text]
  9. Field S, Kelly SM, Macklem PT. The oxygen cost of breathing in patients with cardiorespiratory disease. Am Rev Respir Dis 126: 9–13, 1982.[Web of Science][Medline]
  10. Georgiadou O, Vogiatzis I, Stratakos G, Koutsoukou A, Golemati S, Aliverti A, Roussos C, Zakynthinos S. Effects of rehabilitation on chest wall volume regulation during exercise in COPD patients. Eur Respir J 29: 284–291, 2007.[Abstract/Free Full Text]
  11. Gosker HR, Wouters EF, van d V, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 71: 1033–1047, 2000.[Abstract/Free Full Text]
  12. Harms CA, Babcock MA, McClaran SR, Pegelow DF, Nickele GA, Nelson WB, Dempsey JA. Respiratory muscle work compromises leg blood flow during maximal exercise. J Appl Physiol 82: 1573–1583, 1997.[Abstract/Free Full Text]
  13. Iandelli I, Aliverti A, Kayser B, Dellaca R, Cala SJ, Duranti R, Kelly S, Scano G, Sliwinski P, Yan S, Macklem PT, Pedotti A. Determinants of exercise performance in normal men with externally imposed expiratory flow limitation. J Appl Physiol 92: 1943–1952, 2002.[Abstract/Free Full Text]
  14. Kayser B, Sliwinski P, Yan S, Tobiasz M, Macklem PT. Respiratory effort sensation during exercise with induced expiratory-flow limitation in healthy humans. J Appl Physiol 83: 936–947, 1997.[Abstract/Free Full Text]
  15. Macklem PT. Exercise in COPD: damned if you do and damned if you don't. Thorax 60: 887–888, 2005.[Free Full Text]
  16. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, Leblanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 153: 288–293, 1996.[Abstract]
  17. Mannix ET, Manfredi F, Farber MO. Elevated O2 cost of ventilation contributes to tissue wasting in COPD. Chest 115: 708–713, 1999.[CrossRef][Web of Science][Medline]
  18. Oelberg DA, Kacmarek RM, Pappagianopoulos PP, Ginns LC, Systrom DM. Ventilatory and cardiovascular responses to inspired He-O2 during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158: 1876–1882, 1998.[Abstract/Free Full Text]
  19. Richardson RS, Knight DR, Poole DC, Kurdak SS, Hogan MC, Grassi B, Wagner PD. Determinants of maximal exercise VO2 during single leg knee-extensor exercise in humans. Am J Physiol Heart Circ Physiol 268: H1453–H1461, 1995.[Abstract/Free Full Text]
  20. Roussos C, Macklem PT. The respiratory muscles. N Engl J Med 307: 786–797, 1982.[Web of Science][Medline]
  21. Simon M, Leblanc P, Jobin J, Desmeules M, Sullivan MJ, Maltais F. Limitation of lower limb VO2 during cycling exercise in COPD patients. J Appl Physiol 90: 1013–1019, 2001.[Abstract/Free Full Text]
  22. Vogiatzis I, Zakynthinos S, Georgiadou O, Golemati S, Pedotti A, Macklem PT, Roussos C, Aliverti A. Oxygen kinetics and debt during recovery from expiratory flow-limited exercise in healthy humans. Eur J Appl Physiol 99: 265–274, 2007.[CrossRef][Web of Science][Medline]



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
M. Decramer
Response of the respiratory muscles to rehabilitation in COPD
J Appl Physiol, September 1, 2009; 107(3): 971 - 976.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. J. Tobin, F. Laghi, and L. Brochard
Role of the respiratory muscles in acute respiratory failure of COPD: lessons from weaning failure
J Appl Physiol, September 1, 2009; 107(3): 962 - 970.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. K. McKenzie, J. E. Butler, and S. C. Gandevia
Respiratory muscle function and activation in chronic obstructive pulmonary disease
J Appl Physiol, August 1, 2009; 107(2): 621 - 629.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. R. Chiappa, F. Queiroga Jr., E. Meda, L. F. Ferreira, F. Diefenthaeler, M. Nunes, M. A. Vaz, M. C. L. Machado, L. E. Nery, and J. A. Neder
Heliox Improves Oxygen Delivery and Utilization during Dynamic Exercise in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 1, 2009; 179(11): 1004 - 1010.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. S. Goldstein and T. E. Dolmage
Can We Increase the Exercise Training Load During Pulmonary Rehabilitation?
Chest, March 1, 2009; 135(3): 596 - 598.
[Full Text] [PDF]


This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
105/2/749    most recent
90336.2008v2
90336.2008v1
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aliverti, A.
Right arrow Articles by Macklem, P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aliverti, A.
Right arrow Articles by Macklem, P. T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.